Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Human antibody response to Aedes aegypti saliva in an urban population in Bolivia: a new biomarker of exposure to Dengue vector bites.

Doucoure S, Mouchet F, Cournil A, Le Goff G, Cornelie S, Roca Y, Giraldez MG, Simon ZB, Loayza R, Misse D, Flores JV, Walter A, Rogier C, Herve JP, Remoue F.

Am J Trop Med Hyg. 2012 Sep;87(3):504-10. doi: 10.4269/ajtmh.2012.11-0477. Epub 2012 Jul 30.

2.

Human IgG antibody response to Aedes aegypti Nterm-34 kDa salivary peptide as an indicator to identify areas at high risk for dengue transmission: a retrospective study in urban settings of Vientiane city, Lao PDR.

Ndille EE, Dubot-Pérès A, Doucoure S, Mouchet F, Cornelie S, Sidavong B, Fournet F, Remoue F.

Trop Med Int Health. 2014 May;19(5):576-80. doi: 10.1111/tmi.12280. Epub 2014 Feb 20.

3.

Evaluation of the human IgG antibody response to Aedes albopictus saliva as a new specific biomarker of exposure to vector bites.

Doucoure S, Mouchet F, Cornelie S, DeHecq JS, Rutee AH, Roca Y, Walter A, Hervé JP, Misse D, Favier F, Gasque P, Remoue F.

PLoS Negl Trop Dis. 2012;6(2):e1487. doi: 10.1371/journal.pntd.0001487. Epub 2012 Feb 21.

4.

IgE and IgG4 antibody responses to Aedes saliva in African children.

Remoue F, Alix E, Cornelie S, Sokhna C, Cisse B, Doucoure S, Mouchet F, Boulanger D, Simondon F.

Acta Trop. 2007 Nov-Dec;104(2-3):108-15. Epub 2007 Aug 6.

PMID:
17825239
5.

Human IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission Area.

Elanga Ndille E, Doucoure S, Poinsignon A, Mouchet F, Cornelie S, D'Ortenzio E, DeHecq JS, Remoue F.

PLoS Negl Trop Dis. 2016 Dec 1;10(12):e0005109. doi: 10.1371/journal.pntd.0005109. eCollection 2016 Dec.

6.

Relationship between exposure to vector bites and antibody responses to mosquito salivary gland extracts.

Fontaine A, Pascual A, Orlandi-Pradines E, Diouf I, Remoué F, Pagès F, Fusaï T, Rogier C, Almeras L.

PLoS One. 2011;6(12):e29107. doi: 10.1371/journal.pone.0029107. Epub 2011 Dec 14.

7.

Aedes aegypti anti-salivary gland antibody concentration and dengue virus exposure history in healthy individuals living in an endemic area in Colombia.

Londoño-Rentería B, Cárdenas JC, Giovanni JE, Cárdenas L, Villamizar P, Rolón J, Chisenhall DM, Christofferson RC, Carvajal DJ, Pérez OG, Wesson DM, Mores CN.

Biomedica. 2015 Oct-Dec;35(4):572-81. doi: 10.7705/biomedica.v35i4.2530.

8.

Human antibody response to Aedes albopictus salivary proteins: a potential biomarker to evaluate the efficacy of vector control in an area of Chikungunya and Dengue Virus transmission.

Doucoure S, Mouchet F, Cornelie S, Drame PM, D'Ortenzio E, DeHecq JS, Remoue F.

Biomed Res Int. 2014;2014:746509. doi: 10.1155/2014/746509. Epub 2014 Apr 13.

9.

Characterizing the Aedes aegypti population in a Vietnamese village in preparation for a Wolbachia-based mosquito control strategy to eliminate dengue.

Jeffery JA, Thi Yen N, Nam VS, Nghia le T, Hoffmann AA, Kay BH, Ryan PA.

PLoS Negl Trop Dis. 2009 Nov 24;3(11):e552. doi: 10.1371/journal.pntd.0000552.

10.

[The risk of urban yellow fever outbreaks in Brazil by dengue vectors. Aedes aegypti and Aedes albopictus].

Mondet B, da Rosa AP, Vasconcelos PF.

Bull Soc Pathol Exot. 1996;89(2):107-13; discussion 114. Review. French.

PMID:
8924767
11.
12.

First attempt to validate human IgG antibody response to Nterm-34kDa salivary peptide as biomarker for evaluating exposure to Aedes aegypti bites.

Elanga Ndille E, Doucoure S, Damien G, Mouchet F, Drame PM, Cornelie S, Noukpo H, Yamadjako S, Djenontin A, Moiroux N, Misse D, Akogbeto M, Corbel V, Henry MC, Chandre F, Baldet T, Remoue F.

PLoS Negl Trop Dis. 2012;6(11):e1905. doi: 10.1371/journal.pntd.0001905. Epub 2012 Nov 15.

13.

Dengue vector surveillance in urban residential and settlement areas in Selangor, Malaysia.

Chen CD, Benjamin S, Saranum MM, Chiang YF, Lee HL, Nazni WA, Sofian-Azirun M.

Trop Biomed. 2005 Jun;22(1):39-43.

14.
15.
16.

Natural transovarial dengue virus infection rate in both sexes of dark and pale forms of Aedes aegypti from an urban area of Bangkok, Thailand.

Thongrungkiat S, Wasinpiyamongkol L, Maneekan P, Prummongkol S, Samung Y.

Southeast Asian J Trop Med Public Health. 2012 Sep;43(5):1146-52.

PMID:
23431820
17.

Use of anti-Aedes aegypti salivary extract antibody concentration to correlate risk of vector exposure and dengue transmission risk in Colombia.

Londono-Renteria B, Cardenas JC, Cardenas LD, Christofferson RC, Chisenhall DM, Wesson DM, McCracken MK, Carvajal D, Mores CN.

PLoS One. 2013 Dec 2;8(12):e81211. doi: 10.1371/journal.pone.0081211. eCollection 2013.

18.

Antibody response against saliva antigens of Anopheles gambiae and Aedes aegypti in travellers in tropical Africa.

Orlandi-Pradines E, Almeras L, Denis de Senneville L, Barbe S, Remoué F, Villard C, Cornelie S, Penhoat K, Pascual A, Bourgouin C, Fontenille D, Bonnet J, Corre-Catelin N, Reiter P, Pagés F, Laffite D, Boulanger D, Simondon F, Pradines B, Fusaï T, Rogier C.

Microbes Infect. 2007 Oct;9(12-13):1454-62. Epub 2007 Aug 7.

PMID:
17913537
19.

Some basic biological characteristics of the vector, Aedes aegypti, responsible for dengue virus transmission.

Subhash CA, Agarwal N.

Mil Med. 2004 Aug;169(8):xiii. No abstract available.

PMID:
15379084
20.

[The role of the Aedes aegypti vector in the epidemiology of dengue in Mexico].

Fernández-Salas I, Flores-Leal A.

Salud Publica Mex. 1995;37 Suppl:S45-52. Review. Spanish.

PMID:
8599147

Supplemental Content

Support Center